CBO: Generics Bill Would Save US $4.8 Billion
By William New, Intellectual Property Watch on 09/11/2011 @ 4:30 am
The US Congressional Budget Office has estimated that a current bill to prevent brand-name pharmaceutical companies from paying generic producers to delay the release of generic drugs into the market could save the US budget some $4.8 billion over 10 years.
The bill would treat “pay-for-delay” arrangements as illegal and would give the authority to the Federal Trade Commission to stop them. The bill, the Preserve Access to Affordable Generic Drugs Act (S. 27), is sponsored by Senators Charles Grassley (Republican, Iowa) and Herb Kohl (Democrat, Wisconsin).
The senators have proposed the bill as deficit reduction measure for the government. In addition, the CBO estimates that the bill would cut drug expenditures by about $11 million over the decade.
The CBO study is here  [pdf].
Article printed from Intellectual Property Watch: http://www.ip-watch.org
URL to article: http://www.ip-watch.org/2011/11/09/congressional-budget-office-generics-bill-would-save-us-4-8-billion/
URLs in this post:
 CBO study is here: http://aging.senate.gov/publications/s27.pdf
 US Bill Would Prohibit Generics Delay: http://www.ip-watch.org/2009/06/04/us-bill-would-prohibit-generics-delay/
 US FTC Finds Sharp Rise In ‘Pay-For-Delay’ Deals Blocking Generics: http://www.ip-watch.org/2013/01/18/us-ftc-finds-sharp-rise-in-pay-for-delay-deals-blocking-generics/
 Would Canada-EU Trade Proposals Add $2.8 Billion Price Tag To Drugs Bill?: http://www.ip-watch.org/2011/02/08/would-canada-eu-trade-proposals-add-2-8-billion-price-tag/